Kymera Therapeutics Inc (KYMR)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $10.74B
Last updated: Nov 17, 2026 at 4:35 PM ET
Kymera Therapeutics Inc (KYMR) Stock Chart
Kymera Therapeutics (KYMR) has a latest price of $121.52 on Nov 17, 2026, 15.0% below its 52-week high of $142.92. Its price rose 87.1% over the past 12 months. The month-end price rose 115.1% over the 5 years through Oct 2026, a compound annual rate of 16.6%.
Price Chart
From Aug 2020 to Oct 2026, its highest month-end close was $126.63 in Oct 2026 and its lowest $11.67 in Oct 2023, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart KYMR with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for KYMR.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 4.5%, and over 6 months it rose 55.5%. The month-end price rose 985.1% over the 3 years through Oct 2026, a compound annual rate of 121.4%.
| Period | Change |
|---|---|
| 1 month | +12.4% |
| 3 months | -4.5% |
| 6 months | +55.5% |
| 12 months | +87.1% |
| 12 months, with dividends | +87.1% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +985.1% | +121.4% |
| 5 years | +115.1% | +16.6% |
Price by Year
Its best calendar year was 2025, when the price rose 93.4%, and its weakest was 2022, when it fell 60.7%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $126.63 | +62.7% |
| 2025 | $77.81 | +93.4% |
| 2024 | $40.23 | +58.0% |
| 2023 | $25.46 | +2.0% |
| 2022 | $24.96 | -60.7% |
| 2021 | $63.49 | +2.4% |
Trading Range
The price is 3.5% above its 50-day average of $117.40 and 21.6% above its 200-day average of $99.94.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $121.52 | |
| 52-week high | $142.92 | -15.0% |
| 52-week low | $63.69 | +90.8% |
| 50-day average | $117.40 | +3.5% |
| 200-day average | $99.94 | +21.6% |
Price Risk
Over 3 years, its largest fall from a peak was 59.8%.
| Measure | Value |
|---|---|
| 1-year beta | 0.95 |
| Largest fall, 1 year | -27.7% |
| Largest fall, 3 years | -59.8% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About KYMR
What is KYMR's 1-year price change?
Kymera Therapeutics's price rose 87.1% over the past 12 months. With dividends included, the 12-month total return was 87.1%.
What is KYMR's 5-year price change?
Kymera Therapeutics's month-end price rose 115.1% over the 5 years through Oct 2026, a compound annual rate of 16.6%. These figures leave out dividends.
What is KYMR's 52-week high and low?
Kymera Therapeutics's 52-week high is $142.92 and its 52-week low is $63.69. Its latest price of $121.52 on Nov 17, 2026 is 15.0% below the high.
What is KYMR's beta?
Kymera Therapeutics's 1-year beta against the S&P 500 is 0.95, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 27.7%.
Is the KYMR chart free?
Yes. Advanced Charting for KYMR is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
KYMR pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors